Cardioprotective effect and influence on NOS expression of Montelukast sodium in rats

Yaoxue Xuebao

Volumn 38, Issue 11, 2003, Pages 821-825

  Chen, Shan ^a   Jin, Ge ^b   Shan, Jiang ^a   Zhang, Mei ^c   Men, Qun ^c   Xu, Li ^c  

^a ZHEJIANG UNIVERSITY   (China)

^b ZHEJIANG PROVINCIAL PEOPLE'S HOSPITAL   (China)

^c NONE

Author keywords

Leukotriene; Montelukast sodium; Myocardial necrosis; Nitric oxide; Nitric oxide synthase

Indexed keywords

ACETIC ACID DERIVATIVE; CARDIOTONIC AGENT; ENDOTHELIAL NITRIC OXIDE SYNTHASE; INDUCIBLE NITRIC OXIDE SYNTHASE; ISOPRENALINE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; MONTELUKAST; NITRIC OXIDE SYNTHASE; NOS2 PROTEIN, RAT; NOS3 PROTEIN, RAT; QUINOLINE DERIVATIVE;

ANIMAL; ARTICLE; CHEMICALLY INDUCED DISORDER; ENZYMOLOGY; FEMALE; HEART MUSCLE; HEART MUSCLE ISCHEMIA; MALE; METABOLISM; NECROSIS; PATHOLOGY; RAT; SPRAGUE DAWLEY RAT;

ACETATES; ANIMALS; CARDIOTONIC AGENTS; FEMALE; ISOPROTERENOL; LEUKOTRIENE ANTAGONISTS; MALE; MYOCARDIAL ISCHEMIA; MYOCARDIUM; NECROSIS; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; QUINOLINES; RATS; RATS, SPRAGUE-DAWLEY;

EID: 4344646692     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Ye D, Wang JR . Effects of leukotriene in cardiovascular system [J]. Chin J Intern Med, 1994, 33(9):633-635.
2. Piomelli D, Feinmark SJ, Cannon PJ. Leukotriene biosynthesis by canine and human coronary arteries [J]. J Pharmacol Exp Ther, 1987, 24(3):763-770.
3. Hock CE, Deck LD, Pata LA. Peptide leukotriene receptor antagonism in myocardial ischaemia and reperfusion [J]. Cardiovas Res, 1992, 26(12):1206-1211.
4. Rona G. An infarct-like myocardial lesion and other toxic manifestations produced by isoproterenol in the rats [J]. Arch Pathol Lab Med, 1959, 67(9):442-453.
5. Chen GR, Liu Y, Mao SZ, et al. The effect of Astragalus membranaceus (Fisch) Bge. on lipid peroxidation and NO level of myocardium from rats with diabetic nephropathy [J]. Chin J Appl Physiol, 2001, 17 (2):186-188.
6. Li C, Wang LJ, Zhao ZQ. Quantitative histological measurement of focal myocardial necrosis [J]. J Norman Bethune Univ Med Sci, 1988, 14 (4):314-316.
7. Folco G, Rossini G, Buccellati C, et al. Leukotrienes in cardiovascular diseases [J]. Am J Respir Crit Care Me, 2000, 161(2 pt 2):s112-s116.
8. Li XH, Tang RY. The relationship between white blood cell and myocardial infarction [J]. Chin Pharmacol Bull, 1990, 6(2):65-67.
9. Schulz R, Wamblot R. Inhibition of nitric oxide synthesis protects the isolated working rabbit heart from ischemia-reperfusion injury [J]. Cardiovascu Res, 1995, 30(3):432 -439.
10. Anggard E. Nitric oxide: mediator, murderer, and medicine [J]. Lancet, 1994, 343(8907):1199-1206.
11. Sumeray MS, Rees DD, Yellon DM. Infarct size and nitric oxide synthase in murine myocardium [J]. J Mol Cell Cardiol, 2000, 32(1):35-42.
12. Akiko I, Sadahiro S, Yoshio N, et al. Liposome-mediated gene transfection of endothelial nitric oxide synthase reduces endothelial activation and leukocyte infiltration in transplanted hearts [J]. Circulation, 2001, 103(22):2753-2759.
13. Lynch KR, Oneill GP, Liu QY, et al. Characterization of the human cysteinyl leukotriene CysLT1 receptor [J]. Nature, 1999, 399(6738):789-793.